Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Cough and cold remedies no longer recommended for children under six years

Most over-the-counter cough and cold medicines should no longer be used in children under six years, according to new advice issued by the Medicines and Healthcare products Regulatory Agency on 28 February 2009.

The advice is part of a package of measures recommended by the Commission on Human Medicines to promote the safer use of OTC cough and cold medicines for children under 12 years following a review of the benefits and risks of these medicines by the MHRA.

MHRA review of cough and cold medicines

The review found no evidence that OTC cough and cold medicines have any benefits for children under six years and that they can cause side effects such as allergic reactions, effects on sleep and hallucinations.

OTC cough and cold medicines no longer recommended for children under six years are:

  • Antitussives (dextromethorphan and pholcodine)
  • Expectorants (guaifenesin and ipecacuanha)
  • Nasal decongestants (ephedrine, oxymetazoline, phenylephrine, pseudoephedrine and xylometazoline)
  • Antihistamines (brompheniramine, chlorphenamine, diphenhydramine, doxylamine, promethazine and triprolidine)

For children aged six to 12 years OTC cough and cold medicines containing these ingredients will continue to be available but will only be sold in pharmacies, with clearer advice on the packaging.

The MHRA has stressed that there are no specific safety concerns with these medicines and that companies will be allowed to “sell through” their products.

Other measures include phasing out illogical combinations of ingredients such as cough suppressants and expectorants and ensuring that all cough and cold liquid products, including adult preparations, are in child-resistant containers.

Labelling changes

The pharmaceutical industry has agreed to make the necessary labelling changes to reflect the new advice and will introduce updated labelling and educational material regarding best treatment for coughs and colds in children.

Newly labelled products are expected to start to appear for the 2009 cough and cold season and the changes should be completed by March 2010.

The MHRA has said it will not ask pharmacists to remove medicines with old labelling because many of these products are used in adults and children, and withdrawing the products would cause a shortage. In addition, they say that withdrawing these medicines would not be proportionate to the risk of the side effects.

Products authorised for children aged six to 12 years classified as general sale list (GSL) will have their status changed to pharmacy (P) only medicine.

However, GSL products may continue to be sold on open shelves and remain available through other non-pharmacy settings until new packaging reflecting the P legal status becomes available.

The Society's reaction

Responding (PDF, 47K) to the guidance, David Pruce, director of policy and communications at the Royal Pharmaceutical Society, said the following can be recommended for children under six years who have uncomplicated coughs and colds:

  • Paracetamol or ibuprofen to relieve pain and lower temperature
  • Simple non-pharmacological cough mixtures for the treatment of coughs (eg, paediatric simple linctus or those containing glycerol or honey and lemon)
  • Vapour rubs and inhalant decongestants that can be applied to children's clothing to provide relief of stuffy or blocked nose for children and infants over three months
  • Saline (sodium chloride 0.9 per cent) nose drops — can be helpful particularly in infants who are having difficulty feeding

The Proprietary Association of Great Britain is arranging for leaflets containing information for parents on how to manage coughs and colds in children to be distributed to pharmacies.

Leak forces early release of the information

Asked why the MHRA issued the new advice to the national media at the weekend rather than informing the pharmacy profession of its intentions, a spokesman told The Journal that a leak had forced the MHRA to release the information and that it had not been the agency’s intention to release the information at that time.

He stressed that once the MHRA became aware of this it worked closely with pharmacy groups to give pharmacists, as well as the public, accurate, timely information.

Last year, the MHRA issued advice that children under two years should not be treated with OTC cough and cold medicines. However, the MHRA pointed out that its recent review did not identify the kind of safety issues unearthed at that time.

Citation: The Pharmaceutical Journal URI: 10244795

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Prescribing Medicines for Children

    Prescribing Medicines for Children

    Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.

    £60.00Buy now
  • Introducing Palliative Care (IPC 5)

    Introducing Palliative Care (IPC 5)

    A key resource for students, covering the recommended palliative curriculum for medical undergraduates.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Coughing child

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.